School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6728-31. doi: 10.1016/j.bmcl.2013.10.033. Epub 2013 Oct 26.
An aza-cycloisodityrosine analogue of RA-VII, 3, was designed and synthesized. The key aza-cycloisodityrosine unit was prepared by copper(II)-acetate-mediated intramolecular phenylamine/arylboronic acid coupling of dipeptide followed by connection with the tetrapeptide segment to afford a hexapeptide. Subsequent macrocyclization of the hexapeptide with EDC · HCl and HOOBt under dilute conditions gave 3. Analogue 3 showed significant cytotoxic activity against human promyelocytic leukemia HL-60 cells and human colon carcinoma HCT-116 cells, but its activity was weaker than that of parent peptide RA-VII (1).
设计并合成了 RA-VII 的氮杂环异二酪氨酸类似物 3。关键的氮杂环异二酪氨酸单元是通过二肽的铜(II)-醋酸盐介导的分子内苯胺/芳基硼酸偶联制备的,然后与四肽片段连接得到六肽。随后,在稀条件下用 EDC·HCl 和 HOOBt 使六肽环化得到 3。类似物 3 对人早幼粒细胞白血病 HL-60 细胞和人结肠癌细胞 HCT-116 细胞表现出显著的细胞毒性活性,但活性弱于母体肽 RA-VII(1)。